The Patent Finder
US

ANTI-CD47 Antibody Molecules

US 10,683,350 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Ultrahuman Four Limited, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Aug 17, 2038 · High confidence

Filed Aug 19, 2019 as application 16/543,884 · Granted Jun 16, 2020
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Aug 17, 2018
Term ends
Aug 17, 2038
Granted
Jun 16, 2020
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 17, 2018, when application PCT/GB2018/052347, the earliest non-provisional in its chain, was filed (this one was filed Aug 19, 2019)Aug 17, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 17, 2038High confidence

This family

US 10,683,350this patent
Aug 2038
Aug 2038
US 11,370,840In force
Mar 2039
Mar 2039
Application 17/849,101Abandoned
not computed
not computed
Application 18/893,023Pending
not computed
not computed
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 21, 2019
Reel 50117, frame 304
Finlay, William James JonathanUltrahuman Four LimitedAssignment of Assignor's Interest
Oct 4, 2021
Reel 57710, frame 82
Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Palladio Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor LimitedCocoon S.A. LLCSecurity Interest
Mar 2, 2022
Reel 59304, frame 38
Ultrahuman Four LimitedUltrahuman Four LimitedChange of Registered Office Address
Sep 28, 2023
Reel 65058, frame 96
Ultrahuman Four LimitedCentessa Pharmaceuticals (UK) LimitedAssignment of Assignor's Interest
Dec 31, 2024
Reel 69708, frame 39
Centessa Pharmaceuticals (UK) LimitedOxford Finance LLCSecurity Interest
Jun 12, 2026
Reel 75737, frame 1
Cocoon S.A. LLCApcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Centessa Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCApcintex LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCJanpix LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCapella Bioscience Ltd.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCLockbody Therapeutics Ltd.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCUltrahuman Two LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCUltrahuman Four LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCMorphogen-IX LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCOrexia Therapeutics LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCardiokine Biopharma LLCRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCentessa Biosciences, Inc.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCPearlriver Bio GmbHRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCZ Factor LimitedRelease of Security Interest
Jun 24, 2026
Reel 75069, frame 879
Oxford Finance LLCCentessa Pharmaceuticals (UK) LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited